Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiac Rehabilitation to Improve Breast Cancer Outcomes (CRIBCO)

NCT05867667 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

NCT NCT05867667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05867667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiac Rehabilitation to Improve Breast Cancer Outcomes (CRIBCO)
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Not applicable
Overall status
Terminated
Start date
March 19, 2024
Completion date
August 13, 2024
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cardiovascular diseases